Related Experiment Video
Updated: Jan 11, 2026
10:05
Retinal Organoid Induction System for Derivation of 3D Retinal Tissues from Human Pluripotent Stem Cells
Published on: April 12, 2021
6.7K
Three-dimensional tissue engineering and organoid technologies for retinal regeneration and therapy
Yiqi Wang1,2, Douglas Jiang1, Qinglong Wang1
1Department of Neurology, Beth Israel Deaconess Medical Center Harvard Medical School Boston Massachusetts USA.
Bioengineering & Translational Medicine
|November 17, 2025
Summary
Three-dimensional (3D) bioengineering and organoid technologies offer advanced models for studying retinal diseases and developing therapies. These 3D approaches provide superior tissue architecture and experimental control compared to traditional 2D cultures.
Area of Science:
- Ophthalmology
- Regenerative Medicine
- Biotechnology
Background:
- The human retina converts light into neural signals, and its degeneration causes conditions like glaucoma and macular degeneration.
- Traditional 2D cell cultures lack the complexity and accuracy needed for effective retinal disease modeling.
- Three-dimensional (3D) bioengineering and organoid technologies present advanced alternatives for studying retinal diseases.
Purpose of the Study:
- To review the advancements in organoid generation and 3D bioengineering for retinal disease modeling.
- To evaluate the potential of these technologies in developing translational therapies for retinopathies.
- To compare the efficacy of 3D models with traditional 2D cell cultures.
Main Methods:
- Discussion of organoid generation techniques and their application in retinal disease research.
- Review of various 3D fabrication strategies: bioprinting (inkjet, laser-assisted), electrospun scaffolds, and hydrogel systems.
- Evaluation of the spatial patterning, vascularization, and cell type incorporation in 3D models.
Main Results:
- 3D models, including retinal organoids and engineered constructs, better recapitulate native retinal architecture and functionality.
- Engineered 3D systems allow tailored disease modeling by incorporating specific cell types and parameters for enhanced experimental control.
- Bioprinting and other 3D fabrication methods show significant promise for regenerative medicine and therapeutic development.
Conclusions:
- Organoid and engineered 3D technologies are superior to 2D cultures for modeling retinal diseases and testing therapies.
- These advanced 3D platforms offer greater precision, reproducibility, and potential for developing effective treatments for vision-threatening retinopathies.
- Future research should focus on refining these 3D technologies for broader applications in ophthalmology and regenerative medicine.
